Items where authors include "Whitehead, A."

Article

Crabb, S.J., Danson, S. orcid.org/0000-0002-3593-2890, Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (16 more authors) (2021) Phase I trial of DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine for solid malignancies including urothelial carcinoma (SPIRE). Clinical Cancer Research, 27 (7). pp. 1882-1892. ISSN 1078-0432

Crabb, S., Danson, S.J., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (12 more authors) (2018) SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial. Trials, 19. 216. ISSN 1745-6215

Cooper, C.L. orcid.org/0000-0002-2995-5447, Whitehead, A., Pottrill, E. et al. (2 more authors) (2018) Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials. Clinical Trials, 15 (2). pp. 189-196. ISSN 1740-7745

Teare, M.D., Dimairo, M., Shephard, N. et al. (3 more authors) (2014) Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials, 15. 264. ISSN 1745-6215

Proceedings Paper

Whitehead, A., Cooper, C. orcid.org/0000-0002-2995-5447, Julious, S. et al. (1 more author) (2015) Do pilot trials reliably predict recruitment and retention rates for full trial? A review of HTA funded trials. In: Trials. 3rd International Clinical Trials Methodology Conference, 16-17 Nov 2015, Glasgow, UK. BioMed Central .